SBI Healthcare Opportunities Fund vs Nippon India Pharma Fund compare
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹3933 Cr | ₹8114 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 31 Dec 2004 | 05 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 32% | 21% |
| Expense Ratio | 1.94 | 1.82 |
| Manager | Pradeep Kesavan | Sailesh Raj Bhan |
| ISIN Code | INF200K01446 | INF204K01968 |
| Exits Load | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | 2.52% | 2.16% |
| 6 Month | 3.45% | 3.03% |
| 1 Year | 2.53% | -0.53% |
| 3 Year | 24.41% | 20.87% |
| 5 Year | 19.99% | 18.19% |
SIP Return Analysis
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | -0.66% | -1.64% |
| 1 Year | 2.03% | 0.85% |
| 3 Year | 20.08% | 16.65% |
| 5 Year | 19.02% | 15.98% |
Rolling Lumpsum Returns
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 15.65% | 16.99% |
| 3 Year | 17.81% | 20.8% |
| 5 Year | 12.99% | 20.54% |
Risk Management
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | 14.07% | 15.24% |
| Sharp | 1.18% | 0.90% |
| Beta | 0.84% | 0.91% |
| Alpha | 3.29% | -0.55% |
Fund Managers
| Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Pradeep Kesavan | Sailesh Raj Bhan |
| Total AUM | ₹434274 Cr | ₹96086 Cr |
| Funds Managed | 43 | 5 |
| SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
| Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 13.04 | 1.52 |
| Mid Cap | 27.23 | 33.86 |
| Small Cap | 34.17 | 31.35 |
| Large Cap | 25.56 | 33.27 |
Sector Allocation
| Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 3.64 | 0.53 |
| Basic Materials | 5.69 | - |
| Healthcare | 90.67 | 99.47 |
Top Comparisons
Mahindra Manulife Liquid Fund - Regular Plan - Growth
3Y Returns7%
Tata Liquid Fund -Regular Plan - Growth Option
3Y Returns6.96%
SBI Magnum Income Fund-Regular Plan-Growth
3Y Returns7.46%
HSBC Medium to Long Duration Fund - Regular Growth
3Y Returns6.63%
BANDHAN Flexi Cap Fund - Regular Plan - Growth
3Y Returns15.19%
Aditya Birla Sun Life Flexi Cap Fund - Growth - Regular Plan
3Y Returns17.55%
Kotak ELSS Tax Saver Fund-Scheme-Growth
3Y Returns15.4%
NIPPON INDIA ELSS TAX SAVER FUND-Growth Plan-Growth Option
3Y Returns17.74%